首页 › 基金 › WITTENBERG INVESTMENT MANAGEMENT, INC. › LFCR
WITTENBERG INVESTMENT MANAGEMENT, INC. 对 LFCR 的持仓历史
LIFECORE BIOMEDICAL INC · 医疗保健
WITTENBERG INVESTMENT MANAGEMENT, INC. 在 Q3 2026 的 13F 申报中披露持有 LFCR(LIFECORE BIOMEDICAL INC)305,315 股,市值约 US$2.0M,约占其申报组合的 0.71%,在其申报持仓中市值排名第 22 位。 WITTENBERG INVESTMENT MANAGEMENT, INC. 最近 10 个申报季度中有 10 个季度披露了 LFCR 持仓,最早可追溯至 Q2 2024。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
WITTENBERG INVESTMENT MANAGEMENT, INC. 对 LFCR 的持仓演变
WITTENBERG INVESTMENT MANAGEMENT, INC. 于 Q2 2024 首次披露 LFCR 持仓:14,929 股(约 US$77K)。 该持仓在 Q3 2026 达到峰值 305,315 股,市值约 US$2.0M。 在 10 次申报中,WITTENBERG INVESTMENT MANAGEMENT, INC. 6 次增持、2 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 305,315 股、市值约 US$2.0M,环比减持 -8,700 股。。 持仓曾出现大幅变动:Q3 2024 增持约 288% (随后一个季度股价上涨 51%)、Q4 2024 减持约 81% (随后一个季度股价下跌 5%)、Q1 2026 增持约 1289% (随后一个季度股价上涨 41%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2024 | 14.93K | $76.59K | 新进 |
| Q3 2024 | 57.90K | $285.43K | 增持 |
| Q4 2024 | 11.22K | $83.39K | 减持 |
| Q1 2025 | 12.22K | $86.05K | 增持 |
| Q2 2025 | 17.22K | $139.85K | 增持 |
| Q3 2025 | 17.22K | $126.76K | 持有 |
| Q4 2025 | 21.72K | $177.69K | 增持 |
| Q1 2026 | 301.81K | $1.12M | 增持 |
| Q2 2026 | 314.01K | $1.65M | 增持 |
| Q3 2026 | 305.31K | $2.01M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 LFCR 与 13F 数据
LFCR(LIFECORE BIOMEDICAL INC)属于医疗保健行业。我们追踪的基金中还有 20 只申报持有 LFCR,申报仓位最大的包括:WYNNEFIELD CAPITAL INC (US$24.7M), Legion Partners Asset Management, LLC (US$23.4M), Greenhaven Road Investment Management, L.P. (US$18.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 LFCR 的基金
- WYNNEFIELD CAPITAL INC 4.70M 股 · $24.69M · Q2 2026
- Legion Partners Asset Management, LLC 4.46M 股 · $23.42M · Q2 2026
- Greenhaven Road Investment Management, L.P. 2.87M 股 · $18.88M · Q3 2026
- 325 CAPITAL LLC 2.90M 股 · $15.20M · Q2 2026
- DCF Advisers, LLC 376.50K 股 · $2.48M · Q3 2026
更多关于 WITTENBERG INVESTMENT MANAGEMENT, INC.
常见问题
How long has WITTENBERG INVESTMENT MANAGEMENT, INC. held LFCR?
WITTENBERG INVESTMENT MANAGEMENT, INC. has disclosed LFCR holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is WITTENBERG INVESTMENT MANAGEMENT, INC.'s current position in LFCR?
As of Q3 2026, WITTENBERG INVESTMENT MANAGEMENT, INC. holds 305.31K shares of LFCR (LIFECORE BIOMEDICAL INC), valued at $2.01M, representing 0.71% of its reported portfolio and ranking #22.
Has WITTENBERG INVESTMENT MANAGEMENT, INC. been buying or selling LFCR?
In the latest 13F filing (Q3 2026), WITTENBERG INVESTMENT MANAGEMENT, INC. reduced its position in LFCR. The position peaked in Q3 2026 at 305.31K shares.
Which other funds hold LFCR?
Other major institutional holders of LFCR include WYNNEFIELD CAPITAL INC, Legion Partners Asset Management, LLC, Greenhaven Road Investment Management, L.P., among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.